LuciPona 15 mg is an anticancer medicine used in the treatment of chronic myeloid leukemia and other resistant blood cancers. It is particularly effective in patients with specific genetic mutations. This medicine is widely used across the United Kingdom, United States, Australia, Singapore and Philippines in advanced cancer care. LuciPona helps control disease progression and improves patient outcomes when taken under specialist supervision. Active Ingredient Ponatinib is a tyrosine kinase inhibitor that blocks abnormal proteins responsible for cancer cell growth. It targets specific mutations that make other treatments less effective. Uses of LuciPona 15 mg • Treatment of chronic myeloid leukemia • Management of resistant leukemia cases • Relief from cancer related symptoms • Support for targeted cancer therapy How LuciPona 15 mg Works Ponatinib inhibits tyrosine kinase enzymes involved in cancer cell signaling. This prevents abnormal cell growth and induces cancer cell death thereby controlling disease progression. How to Use LuciPona 15 mg 1. Take once daily as prescribed 2. Swallow whole with water 3. Follow medical instructions strictly Possible Side Effects • Hypertension • Fatigue • Abdominal pain • Rash Precautions • Monitor blood pressure regularly • Inform doctor about heart conditions • Avoid during pregnancy Safety Information Use under strict medical supervision. Regular monitoring is required to manage potential side effects and ensure treatment safety. Storage • Store below 30°C • Keep in original packaging • Keep away from children